The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.

about

The Effects of the Recombinant CCR5 T4 Lysozyme Fusion Protein on HIV-1 Infection.CCR5 blockade for neuroinflammatory diseases--beyond control of HIV.SPG5 and multiple sclerosis: clinical and genetic overlap?

P2860

Q35685881-A9C56E54-18FC-4EBD-A3EC-FAA2F0F75475 Q38702121-65F915BF-A63D-4A88-88B5-881EA4B85CA4 Q52149273-D6B17D24-E8F6-4809-A75F-04AC9D10B169

P2860

The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.

Item

http://www.wikidata.org/entity/Q50998405

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.

@en

The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.

@nl

type

Item

label

The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.

@en

The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.

@nl

prefLabel

The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.

@en

The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.

@nl

P1476

The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.

@en

P2093

A B Oturai

http://www.w3.org/2001/XMLSchema#string

F Sellebjerg

http://www.w3.org/2001/XMLSchema#string

H B Søndergaard

http://www.w3.org/2001/XMLSchema#string

M Møller

http://www.w3.org/2001/XMLSchema#string

N Koch-Henriksen

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

CD4(+) memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis

Multiple sclerosis

Endogenous and recombinant type I interferons and disease activity in multiple sclerosis

Lymphocyte subsets show different response patterns to in vivo bound natalizumab--a flow cytometric study on patients with multiple sclerosis

Chemokines: a new classification system and their role in immunity

The many roles of chemokines and chemokine receptors in inflammation

C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE.

Cutting edge: loss of α4 integrin expression differentially affects the homing of Th1 and Th17 cells

Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE

P304

27-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ANE.12145

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P50

Per Soelberg Sørensen

P577

2013-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236738347

http://www.w3.org/2001/XMLSchema#string

P698

23668375

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.

about

P2860

P2860

The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921